This brand name is authorized in Austria, Brazil, Canada, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Germany, Hong Kong SAR China, Ireland, Israel, Lithuania, Mexico, Netherlands, Nigeria, Poland, Romania, Singapore, South Africa, Spain, Tunisia, Turkey, UK.
The drug AVAMYS contains one active pharmaceutical ingredient (API):
1
|
UNII
JS86977WNV - FLUTICASONE FUROATE
|
|
Fluticasone furoate is a synthetic trifluorinated corticosteroid that possesses a very high affinity for the glucocorticoid receptor and has a potent anti-inflammatory action. |
|
Below package inserts are available for further reading:
| Document | Type | Information Source | |
|---|---|---|---|
| AVAMYS Nasal spray, suspension | MPI, EU: SmPC | European Medicines Agency (EU) |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| R01AD12 | Fluticasone furoate | R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use → R01AD Corticosteroids |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| BR | Câmara de Regulação do Mercado de Medicamentos | 510611301139217 |
| CA | Health Products and Food Branch | 02298589 |
| DE | Bundesinstitut für Arzneimittel und Medizinprodukte | 01329937, 02425979, 13696167 |
| EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | 28526-08-08, 7375-MEE-0722 |
| EE | Ravimiamet | 1343012, 1343023, 1343034 |
| ES | Centro de información online de medicamentos de la AEMPS | 07434003, 07434003IP, 07434003IP1, 07434003IP4 |
| FI | Lääkealan turvallisuus- ja kehittämiskeskus | 088261 |
| FR | Base de données publique des médicaments | 66921927 |
| GB | Medicines & Healthcare Products Regulatory Agency | 150464, 180514, 381185 |
| HK | Department of Health Drug Office | 56691 |
| IE | Health Products Regulatory Authority | 53605, 53612, 53625, 53632, 53645 |
| IL | מִשְׂרַד הַבְּרִיאוּת | 6400 |
| LT | Valstybinė vaistų kontrolės tarnyba | 1005666, 1032059, 1032060 |
| MX | Comisión Federal para la Protección contra Riesgos Sanitarios | 214M2009 |
| NG | Registered Drug Product Database | A4-4904 |
| NL | Z-Index G-Standaard | 14236664 |
| NL | Z-Index G-Standaard, PRK | 85847 |
| PL | Rejestru Produktów Leczniczych | 100181056 |
| RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | W65298001, W65298002, W65298003 |
| SG | Health Sciences Authority | 13666P |
| TN | Direction de la Pharmacie et du Médicament | 24833011, 2883011 |
| TR | İlaç ve Tıbbi Cihaz Kurumu | 8699522541379 |
| ZA | Health Products Regulatory Authority | 41/21.5.1/0968 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.